CFO of Hims & Hers Uses 10b5‑1 Plan to Buy Low Amid Market Slide, Leaves Holdings Steady at ~91,600 Shares
Explore how CFO Okupe Oluyemi’s disciplined 10b5‑1 trades reveal investor confidence in Hims & Hers Health amid a market dip, AI‑driven growth, and a high valuation.
3 minutes to read